Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: September 15, 2010

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Zirgan	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Oravig	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Cetraxal	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Lysteda	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Oleptro	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Pancreaze	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Xifaxan 550	New Drug Appeal	Require Prior Approval	Prior Approval Required
Bepreve	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Colcrys	New Drug Appeal	Require Prior Approval	Prior Approval Required
Fanapt	New Drug Appeal	Removed from Agenda Prior to Mtg	Prior Approval Required
Pristiq	New Drug Appeal	Require Prior Approval	Prior Approval Required
Saphris	PDL Appeal	Remove Prior Approval Requirement	Prior Approval Required
Vesicare	PDL Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed

Footer